PDB reference: MK2-TEI- L03090 complex, 3wi6 Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2), a serine/threonine kinase from the p38 mitogen-activated protein kinase signalling pathway, plays an important role in the production of TNF-and other cytokines. In a previous report, it was shown that MK2 in complex with the selective inhibitor TEI-I01800 adopts an -helical glycine-rich loop that is induced by the stable nonplanar conformer of TEI-I01800. To understand the mechanism of the structural change, the structure of MK2 bound to TEI-L03090, which lacks the key substituent found in TEI-I01800, was determined. MK2-TEI-L03090 has a -sheet glycine-rich loop in common with other kinases, as predicted. This result suggests that a small compound can induce a drastic conformational change in the target protein structure and can be used to design potent and selective inhibitors.
Introduction
Mitogen-activated protein kinase-activated protein kinase 2 (MK2 or MAPKAP-K2), a serine/threonine kinase from the p38 mitogenactivated protein kinase (p38 MAPK) signalling pathway, plays an important role in the production of TNF-and other cytokines (Beyaert et al., 1996) . p38 MAPK signalling plays a role in a variety of inflammatory and other conditions, such as asthma, rheumatoid arthritis, Crohn's disease, atherosclerosis and cancer. Therefore, inhibition of the p38 MAPK pathway is a promising anti-inflammatory drug target (Cuenda & Rousseau, 2007) . MK2 is a downstream kinase of p38 MAPK that is directly phosphorylated by p38 MAPK and that has also attracted attention as a target for anti-inflammatory therapy (Gaestel et al., 2007; Ronkina et al., 2010) . In fact, several groups have developed programs for anti-inflammatory therapies by generating MK2 inhibitors and have reported crystal structures of MK2 (Wu et al., 2007; Hilling et al., 2007; Anderson et al., 2007; Revesz et al., 2010; Velcicky et al., 2010; Argiriadi et al., 2009 Argiriadi et al., , 2010 Fujino et al., 2010; Barf et al., 2011; Oubrie et al., 2012) .
Protein kinases frequently contain a glycine-rich loop with a consensus sequence (Gly-X-Gly-X-X-Gly) in its N-lobe domain. This loop is part of a -hairpin that connects the 1 and 2 strands and forms a -sheet structure that interacts with ATP. MK2 also has a glycine-rich loop sequence 71 Gly-Leu-Gly-Ile-Asn-Gly 76 and, with the exception of two structures of complexes with inhibitors, TEI-I01800 (PDB entry 3a2c; Fujino et al., 2010) and a 2,4-diaminopyrimidine derivative from Abbott (PDB entry 3ka0; Argiriadi et al., 2010) , all MK2 complexes deposited in the PDB have a -sheet glycine-rich loop (-form).
Protein kinases are key regulators of cell function and constitute one of the largest and most functionally diverse gene families. Kinases are particularly prominent in signal transduction and the coordination of complex functions, in particular the serine/threonine kinase cyclin-dependent kinase 2 (CDK2), which plays a central role in controlling the cell cycle (Tsai et al., 1991) . Furthermore, interference with the cell cycle via inhibition is likely to be an undesirable feature for chronically used anti-inflammatory drugs, such as an MK2 inhibitor. TEI-I01800 is highly potent and selective against significant kinases and has a 177-fold selectivity for MK2 over CDK2 (its IC 50 values for MK2 and CDK2 are 0.13 and 23 mM, respectively). Furthermore, we have previously reported crystal structures of MK2 and CDK2 in complex with TEI-I01800 (Fujino et al., 2010 (Fujino et al., , 2013 Kosugi et al., 2012) , which revealed that MK2-TEI-I01800 forms an uncommon -helical glycine-rich loop (-form) which is induced by the stable conformer of TEI-I01800. On the other hand, CDK2-TEI-I01800 adopted the -form commonly observed in CDK2 complexes with a small inhibitor. These results suggest that collision between Leu70 and the p-ethoxyphenyl group at the 7-position of TEI-I01800 triggers a structural change in the glycine-rich loop of MK2. Moreover, the 177-fold selectivity for MK2 over CDK2 is caused by favourable interactions between the MK2-specific hydrophobic pocket exposed by the structural change and TEI-I01800.
TEI-L03090, a derivative of this MK2 inhibitor, exhibited a 7.4-fold selectivity for CDK2 over MK2 (its IC 50 values for MK2 and CDK2 were 4.7 and 0.63 mM, respectively). This inhibitor lacks a functional group at the position corresponding to the p-ethoxyphenyl group of TEI-I01800. In order to understand the mechanism of structural change and selectivity, we determined the crystal structure of MK2 in complex with TEI-L03090. Our results show that MK2-TEI-L03090 adopts the -form, providing a better understanding of the crucial residue required for structural change and selectivity.
Materials and methods
The human MK2 protein was purified using a modified version of our previously described method (Fujino et al., 2010) . Purified MK2 was concentrated to 5 mg ml À1 (0.13 mM) and added to TEI-L03090 at a final concentration of 2 mM. Co-crystallization experiments of MK2-TEI-L03090 were performed using the hanging-drop vapourdiffusion method under the following conditions: 0.1 M sodium acetate pH 5.0, 1.6 M ammonium sulfate, 200 mM sodium chloride, 1.4 mM Deoxy Big CHAP. These conditions were modified from those used for MK2-TEI-I01800; Deoxy Big CHAP significantly changed the appearance and the diffraction limit of the crystals. X-ray diffraction data were collected on the BL41XU beamline at SPring-8 at 100 K using 28% sucrose as a cryoprotectant. The MK2-TEI-L03090 complex crystals diffracted to 3.0 Å resolution and belonged to space group I2 1 2 1 2 1 , with unit-cell parameters a = 180.06, b = 179.68, c = 254.10 Å . The crystal contained six monomer molecules in the asymmetric unit, with a Matthews coefficient (V M ) of 4.57 Å 3 Da À1 and a solvent content (V solv ) of 73.1%. The reflection data were processed with HKL-2000 (Otwinowski & Minor, 1997) and molecular replacement was performed by MOLREP (Vagin & Teplyakov, 2010) from CCP4 using the MK2-ADP structure (PDB entry 1ny3; Underwood et al., 2003 ) as a search model. Six monomer molecules were found in an asymmetric unit with R = 41.3% and a score of 66.7%. Rigid-body refinement was then performed using REFMAC (Murshudov et al., 2011) . After rigid-body refinement and restrained refinement with NCS constraints, the R and R free factors were 37.7 and 37.6%, respectively. The electrondensity maps for TEI-L03090 were generated and assigned using Coot (Emsley & Cowtan, 2004) , and the R and R free factors reduced to 23.8 and 29.1%, respectively. Structure refinement was continued until the R and R free factors were 24.0 and 28.3%, respectively, without NCS constraints. The statistics of data collection and the final structure are summarized in Table 1 . The atomic coordinates and structure factors have been deposited in the PDB with accession code 3wi6. All figures were produced using Discovery Studio (Accelrys; http://accelrys.com/).
Results and discussion
Unlike other reported MK2 crystals, the crystal of MK2-TEI-L03090 belonged to space group I2 1 2 1 2 1 and contained two trimers in an asymmetric unit ( Figs. 1b and 1c ). Similar to MK2-TEI-I01800, the substrate-binding pocket of molecule A interacted with part of a neighbouring molecule (molecule C, residues 228-235) in the asymmetric unit and the N-terminus interacted with a neighbouring molecule related by the 2 1 screw axis. As a result, MK2-TEI-L03090 exhibited a similar oligomerization state, which consisted of 12 molecules of MK2-TEI-I01800. The root-mean-square deviation (r.m.s.d.) on C atoms between the monomers of MK2-TEI-L03090 is less than 1 Å . Molecule A, which had the lowest average B factor, was selected as the monomer structure and is discussed below.
The monomer structure of MK2-TEI-L03090 is shown in Fig. 1(a) . Residues 154-156, 217-226, 239-240 and 266-270 were disordered and poor density maps were obtained. TEI-L03090 was bound to the ATP-binding pocket and the glycine-rich loop formed a -sheet structure similar to that in MK2-ADP (PDB entry 1ny3) and other MK2-inhibitor complexes. The r.m.s.d. on C atoms between MK2-TEI-L03090 and MK2-ADP was 0.60 Å .
The molecular structure and atomic numbering of TEI-L03090 and TEI-I01800 are shown in Fig. 2 . TEI-L03090 cyclized between the 6-and 7-positions of TEI-I01800 and has a pyrazolo[1,5-a]pyrrolo-[3,2-e]pyrimidine scaffold with a (3S)-piperidylamino group at the 5-position. Its inhibitory activities (IC 50 ) against MK2 and CDK2 are 4.7 and 0.63 mM, respectively.
The density map and interactions of TEI-L03090 are shown in Fig. 3 . TEI-L03090 interacted with the backbone amide of Leu141 through the two hydrogen bonds TEI-L03090 N1Á Á ÁLeu141 N (3.3 Å ) and TEI-L03090 N8Á Á ÁLeu141 O (2.7 Å ). The N16 atom of TEI-L03090 may be ionized and interact with the carbonyl group of Asp207 
Figure 2
Molecular structures of (a) TEI-L03090 and (b) TEI-L01800. Fig. 4 shows a comparison between the interactions in MK2-TEI-L03090 and MK2-TEI-I01800. Interestingly, TEI-L03090 did not change the conformation of the glycine-rich loop. The average r.m.s.d. between all C atoms of the two complex structures was 1.96 Å . However, the average r.m.s.d. of the -form or -form region, 65 VTAQVLGLGINGKVLQ 80 , which contains the glycine-rich loop sequence, was the largest (6.93 Å ). The interactions of TEI-L03090 with Leu141, Glu190, Asn191 and Asp207 were similar to those of MK2-TEI-I01800 (Fig. 5) . However, the distances of these hydrogen bonds, with the exception of TEI-L03090 N8Á Á ÁLeu141 O, were longer than those in MK2-TEI-I01800. These long hydrogen bonds could be the reason why TEI-L03090 shows weak inhibition. Furthermore, the interactions between Cys140 and TEI-I01800 are important for MK2 activity, as described in our previous study (Fujino et al., 2010 (Fujino et al., , 2013 Kosugi et al., 2012) . TEI-L03090 lacked van der Waals contacts with Cys140 because TEI-L03090 lacks a substituent at the 8-position corresponding to the p-ethyoxyphenyl group at the 7-position of TEI-I01800. The inhibitory activity also decreased in the absence of Cys140 interactions.
In order to bind to Cys140, TEI-I01800 modified the glycine-rich loop of MK2 from the -form to the -form because Cys140 is only exposed when this structural change occurs (Fig. 4b ). We speculate that collision between Leu70 and the p-ethoxyphenyl group at the 7-position of TEI-I01800 triggers this structural change. The p-ethoxyphenyl group at the 7-position is the only structural difference between TEI-I01800 and TEI-L03090. Therefore, the fact that TEI-L03090 does not induce this structural change is consistent with our hypothesis that the structural change is caused by the collision of Leu70 and TEI-I01800.
TEI-L03090 showed inhibitory activity against not only MK2 and CDK2 but also other kinases (data not shown), which may be owing to interactions with hinge and phosphate-binding regions that are highly conserved in the kinase family. Moreover, TEI-L03090 is planar because of cyclization between the 6-and 7-positions of TEI-I08000 and can bind the -form pockets of various kinases. On the other hand, the stable conformer of the selective inhibitor TEI-I01800 was nonplanar, favouring the induced -form pocket over the -form pocket. Thus, our data also support the high selectivity of TEI-I01800 being a consequence of its characteristic interactions with the -form of MK2.
In this communication, we solved the crystal structure of MK2 in complex with the non-selective inhibitor TEI-L03090, which inhibits MK2, CDK2 and other kinases. MK2 adopts a -form in this complex, as we predicted because TEI-L03090 lacks a substituent that collides with Leu70 in the glycine-rich loop. These results strongly support the structural change of MK2 from the -form to the -form being Top view (a) and side view (b) of the binding interactions of MK2 with TEI-L03090 (green) and TEI-I01800 (red).
Figure 4
Structural comparison of the glycine-rich loops and the key residues Leu70 and Cys140 in (a) MK2-TEI-L03090 (-form of residues 65 VTAQVLGLGINGKVLQ 80 with large conformational changes, green; glycine-rich loop, blue) and (b) MK2-TEI-I01800 (-form of the same residues, red; glycine-rich loop, blue). induced by collisions between Leu70 and TEI-I01800, and this structural change increases its selectivity for MK2 over CDK2. Thus, our research suggests that a small compound can induce a drastic conformational change in a target protein structure, and this phenomenon may be useful in developing potent and selective inhibitors.
